Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Signal generation and clarification: use of case-control data.

D W Kaufman1, L Rosenberg, A A Mitchell

  • 1Slone Epidemiology Unit, Boston University School of Medicine, 1371 Beacon Street, Brookline, MA 02446, USA. david@slone.bu.edu

Pharmacoepidemiology and Drug Safety
|August 15, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A telephone intervention to achieve differentiation in dietary intake: a randomized trial in paediatric primary care.

Pediatric obesity·2016
Same author

Research challenges for drug-induced birth defects.

Clinical pharmacology and therapeutics·2016
Same author

Registered Replication Report: Schooler and Engstler-Schooler (1990).

Perspectives on psychological science : a journal of the Association for Psychological Science·2015
Same author

Survival in commercially insured multiple sclerosis patients and comparator subjects in the U.S.

Multiple sclerosis and related disorders·2015
Same author

Maternal hypertensive disorders, antihypertensive medication use, and the risk of birth defects: a case-control study.

BJOG : an international journal of obstetrics and gynaecology·2014
Same author

Adverse drug reactions in utero: perspectives on teratogens and strategies for the future.

Clinical pharmacology and therapeutics·2011
Same journal

A Drug-Environment Interaction Between PM<sub>2</sub> <sub>.5</sub> Concentration and Corticosteroid Use on Cardiovascular and Thromboembolic Events in Older Adults.

Pharmacoepidemiology and drug safety·2026
Same journal

Association Between Socioeconomic Conditions and Biologic Prescriptions for Inflammatory Bowel Diseases in the Brazilian Public Healthcare System: An Ecological Study.

Pharmacoepidemiology and drug safety·2026
Same journal

Effectiveness of Metformin in Preventing Colorectal Cancer Among Japanese Patients With Type 2 Diabetes: A Target Trial Emulation.

Pharmacoepidemiology and drug safety·2026
Same journal

Trends in Pharmacist-Prescribed Dispensing Records of HIV Pre-Exposure (2020-2025) and Post-Exposure Prophylaxis (2020-2024) in Brazil: A Time Series Analysis.

Pharmacoepidemiology and drug safety·2026
Same journal

French Consumption of Methylphenidate in Primary Care From 2016 to 2023, Impact of Prescribing Policy Changes-A Time-Series Analysis.

Pharmacoepidemiology and drug safety·2026
Same journal

Uptake and Use of Biologic Therapies in Paediatric Immune-Mediated Inflammatory Diseases: An Australian Population-Based Study.

Pharmacoepidemiology and drug safety·2026
See all related articles

Case-control surveillance systems effectively identify potential adverse drug effects. These systems provide detailed data for in-depth analysis, reducing false alarms in drug safety monitoring.

Area of Science:

  • Pharmacovigilance
  • Epidemiology
  • Drug Safety

Background:

  • Established case-control surveillance systems have monitored drug effects since 1976.
  • These systems collect extensive data on diagnoses and covariates.

Purpose of the Study:

  • To highlight the utility of case-control surveillance systems for generating signals of potential adverse drug events.
  • To emphasize the capacity of these systems for in-depth analysis and confounding control.

Main Methods:

  • Utilizing established case-control surveillance systems, including the Slone Epidemiology Unit's Case-Control Surveillance and the Birth Defects Study.
  • Leveraging extensive data on patient diagnoses and covariates for detailed analysis.

Main Results:

Related Experiment Videos

  • Case-control surveillance systems are effective in 'signal' generation for previously unidentified adverse drug effects.
  • In-depth analyses with specifically defined outcomes and controlled confounding reduce the likelihood of false alarms.

Conclusions:

  • Case-control surveillance systems are valuable tools for early detection of adverse drug reactions.
  • The detailed data and analytical capabilities of these systems enhance the reliability of drug safety signals.